ANDA 78439, held by Lannett. Hydromorphone Hydrochloride.
As of Nov 16, 2026, ANDA 78439 (Hydromorphone Hydrochloride), held by Lannett, was first approved by FDA on Dec 9, 2009, with 0 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Dec 9, 2009 | Original application | Approved | None posted |
| Hydromorphone Hydrochloride2MG · tablet;oral | Hydromorphone Hydrochloride | Rx |
| Hydromorphone Hydrochloride4MG · tablet;oral | Hydromorphone Hydrochloride | Rx |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters